v3.24.1.u1
Stock-Based Compensation (Tables)
 9 Months Ended
Mar. 29, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity of the Company's stock option plans since June 30, 2023:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as of 3/29/24
Outstanding at June 30, 2023— $— $— — — 
Granted934 12.71 45.00 
Exercised— — 
Canceled— — 
Outstanding at March 29, 2024934 $12.71 $45.00 2.93 years— 
Exercisable at March 29, 2024— $— $— — — 
Schedule of Valuation assumptions The Company calculated the fair values of the options grants using the following weighted-average assumptions:
Third Quarter Ended
March 29, 2024
Expected volatility45 %
Expected term4 years
Risk-free interest rate4.44 %
Expected dividend yield— %
Weighted-average grant date fair value per share$12.71 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 30, 2023:
 Non-vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Outstanding at June 30, 20231,339 $54.45 
Granted1,334 36.38 
Vested(435)56.80 
Forfeited(557)47.90 
Outstanding at March 29, 20241,681 $41.66 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive (Loss) Income:

 Third Quarters EndedNine Months Ended
 March 29, 2024March 31, 2023March 29, 2024March 31, 2023
Cost of revenues$1,299 $630 $2,119 $1,666 
Selling, general and administrative4,123 7,577 11,626 20,732 
Research and development1,498 1,732 4,678 5,048 
Stock-based compensation expense before tax6,920 9,939 18,423 27,446 
Income taxes(1,868)(2,684)(4,974)(7,410)
Stock-based compensation expense, net of income taxes$5,052 $7,255 $13,449 $20,036